Revenue: The sum of all revenue fields included for a company's operating activities.
Cocrystal Pharma, Inc. (COCP) Revenue data is not available for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
-- |
$-17.50M |
|
-- |
|
-- |
|
$17.88M |
|
$-17.88M |
|
$0.37M |
|
$-17.50M |
|
$-17.50M |
|
$-17.50M |
|
$-17.50M |
|
$-17.50M |
|
$-17.50M |
|
$-17.88M |
|
$-17.43M |
|
10.17M |
|
10.17M |
|
$-1.72 |
|
$-1.72 |
|
| Balance Sheet Financials | |
$11.58M |
|
$0.15M |
|
$1.88M |
|
$13.46M |
|
$2.43M |
|
-- |
|
$1.50M |
|
$3.93M |
|
$9.52M |
|
$9.52M |
|
$9.52M |
|
10.17M |
|
| Cash Flow Statement Financials | |
$-16.48M |
|
$-0.01M |
|
-- |
|
$26.43M |
|
$9.94M |
|
$-16.49M |
|
$0.64M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.77 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-16.49M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-183.81% |
|
-183.81% |
|
-130.08% |
|
-183.81% |
|
$0.94 |
|
$-1.62 |
|
$-1.62 |
|